Patients On patient-centric treatment decisions and the value of quan... Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, discusses the pressing need for quantitative methodologies.
Patients The need for a science-first mindset: The vaccine landscape ... In a new pharmaphorum podcast, Rebecca Catterick, previously at Sanofi, discusses the decline in vaccination rates.
Patients The ins and outs of HEOR – A lever for global health Web editor Nicole Raleigh speaks with Rob Abbott, CEO and executive director of ISPOR, about the ins and outs and trends of HEOR.
Patients Prevention for a healthier, more productive society During Anthropy 2025: Rebooting Britain, web editor Nicole Raleigh spoke with David Gillen, chief medical officer at Norgine.
Patients For the continuum of mental health we need a whole system, h... If we don’t address the mental health of young people, that mental health challenge will advance into the adult population of tomorrow.
News Novartis sets sights on new oral MS drug after phase 3 wins Novartis' oral BTK inhibitor remibrutinib has shown efficacy in a pair of phase 3 trials in multiple sclerosis, boosting its blockbuster credentials.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
